Anixa Strengthens Global Intellectual Property for Ovarian Cancer Prevention Vaccine
Biotech firm Anixa has expanded its international patent protections for a vaccine aimed at preventing ovarian cancer, reinforcing its position in the oncology space.
Biotech firm Anixa has expanded its international patent protections for a vaccine aimed at preventing ovarian cancer, reinforcing its position in the oncology space.